Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Apr-May:47:100979.
doi: 10.1016/j.nmni.2022.100979. Epub 2022 Apr 11.

Computational repurposing of asthma drugs as potential inhibitors of SARS-CoV-2 Mpro

A Hussain  1 , A Hussain  2
Affiliations

Computational repurposing of asthma drugs as potential inhibitors of SARS-CoV-2 Mpro

A Hussain et al. New Microbes New Infect. 2022 Apr-May.
No abstract available

Keywords: Asthma drugs; COVID-19; SARS-CoV-2; drug repurposing; molecular docking.

PubMed Disclaimer

Similar articles

See all similar articles

References

    1. Hu B., Guo H., Zhou P., Shi Z.L. Characteristics of SARS-CoV-2 and COVID-19. Nat Rev Microbiol. 2021;19(3):141–154. - PMC - PubMed
    1. Liu Y.C., Kuo R.L., Shih S.R. COVID-19: the first documented coronavirus pandemic in history. Biomed J. 2020;43(4):328–333. - PMC - PubMed
    1. Jean S.S., Lee P.I., Hsueh P.R. Treatment options for COVID-19: the reality and challenges. J Microbiol Immunol Infect. 2020;53(3):436–443. - PMC - PubMed
    1. Vitiello A., Ferrara F. Remdesivir versus ritonavir/lopinavir in COVID-19 patients. Irish J Med Sci. 2021;190(3):1249–1250. - PMC - PubMed
    1. Gaudêncio S.P., Pereira F. A computer-aided drug design approach to predict marine drug-like leads for SARS-CoV-2 main protease inhibition. Marine Drugs. 2020;18(12) - PMC - PubMed